11LBA Differences in the quality of life (QoL) and functional outcomes of treatment between HPV associated (HPV+) and HPV- patients receiving primary chemoradiotherapy in PET-NECK - a multi-centre randomized phase III controlled trial (RCT) comparing PETCT guided active surveillance with planned neck dissection (ND) for locally advanced (N2/N3) nodal metastases (LANM) in patients with head and neck squamous cell cancer (HNC) treated with primary radical chemoradiotherapy (CRT)

Hisham M. Mehanna,Wai Lup Wong,Christopher C. McConkey,Joy K Rahman,Max Robinson,A. Hartley,Christopher M. Nutting,Ned George Powell,H. Al-Booz,Elizabeth Junor,Claire Hulme,Alison Smith,Peter Hall,Janet A. Dunn

11LBA Differences in the quality of life (QoL) and functional outcomes of treatment between HPV associated (HPV+) and HPV- patients receiving primary chemoradiotherapy in PET-NECK - a multi-centre randomized phase III controlled trial (RCT) comparing PETCT guided active surveillance with planned neck dissection (ND) for locally advanced (N2/N3) nodal metastases (LANM) in patients with head and neck squamous cell cancer (HNC) treated with primary radical chemoradiotherapy (CRT)

2015

11LBA LATE-BREAKING ABSTRACT Differences in the quality of life (QoL) and functional outcomes of treatment between HPV associated (HPV+) and HPV− patients receiving primary chemoradiotherapy in PET-NECK − a multi-centre randomized phase III controlled trial (RCT) comparing PETCT guided active surveillance with planned neck dissection (ND) for locally advanced (N2/N3) nodal metastases (LANM) in patients with head and neck squamous cell cancer (HNC) treated with primary radical chemoradiotherapy (CRT)

Keywords:

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations